SMT201500098B - Acidi 2-aril-propionici e derivati e composizioni farmaceutiche che li contengono - Google Patents
Acidi 2-aril-propionici e derivati e composizioni farmaceutiche che li contengonoInfo
- Publication number
- SMT201500098B SMT201500098B SM201500098T SM201500098T SMT201500098B SM T201500098 B SMT201500098 B SM T201500098B SM 201500098 T SM201500098 T SM 201500098T SM 201500098 T SM201500098 T SM 201500098T SM T201500098 B SMT201500098 B SM T201500098B
- Authority
- SM
- San Marino
- Prior art keywords
- aryl
- derivatives
- pharmaceutical compositions
- compositions containing
- propionic acids
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/48—Nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Transplantation (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08164605A EP2166006A1 (en) | 2008-09-18 | 2008-09-18 | 2-aryl-propionic acids and derivatives and pharmaceutical compositions containing them |
| PCT/EP2009/062109 WO2010031835A2 (en) | 2008-09-18 | 2009-09-18 | 2-aryl-propionic acids and derivatives and pharmaceutical compositions containing them |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SMT201500098B true SMT201500098B (it) | 2015-07-09 |
Family
ID=40291117
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SM201500098T SMT201500098B (it) | 2008-09-18 | 2015-04-22 | Acidi 2-aril-propionici e derivati e composizioni farmaceutiche che li contengono |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US8624036B2 (it) |
| EP (2) | EP2166006A1 (it) |
| JP (1) | JP5571669B2 (it) |
| CN (1) | CN102159558B (it) |
| AU (1) | AU2009294558B2 (it) |
| BR (1) | BRPI0918759A2 (it) |
| CA (1) | CA2737099C (it) |
| CY (1) | CY1116176T1 (it) |
| DK (1) | DK2346841T3 (it) |
| ES (1) | ES2534634T3 (it) |
| HR (1) | HRP20150395T1 (it) |
| IL (1) | IL211683A (it) |
| PL (1) | PL2346841T3 (it) |
| PT (1) | PT2346841E (it) |
| RU (1) | RU2520212C2 (it) |
| SI (1) | SI2346841T1 (it) |
| SM (1) | SMT201500098B (it) |
| WO (1) | WO2010031835A2 (it) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3040336T3 (da) | 2012-03-02 | 2020-06-22 | Sareum Ltd | Forbindelser til brug i behandling af TYK2 Kinase-medierede tilstande |
| US10046002B2 (en) | 2013-08-02 | 2018-08-14 | Syntrix Biosystems Inc. | Method for treating cancer using chemokine antagonists |
| US10561676B2 (en) * | 2013-08-02 | 2020-02-18 | Syntrix Biosystems Inc. | Method for treating cancer using dual antagonists of CXCR1 and CXCR2 |
| BR112016004723B1 (pt) * | 2013-09-03 | 2022-08-30 | Sareum Limited | Compostos de pirrolidina ou morfolina e composição contendo os mesmos |
| AR103399A1 (es) * | 2015-01-15 | 2017-05-10 | Actelion Pharmaceuticals Ltd | Derivados de (r)-2-metil-piperazina como moduladores del receptor cxcr3 |
| EP3117835A1 (en) * | 2015-07-14 | 2017-01-18 | Dompé farmaceutici s.p.a. | Il-8 inhibitors for use in the treatment of certain urological disorders |
| EP3192504A1 (en) | 2016-01-15 | 2017-07-19 | Dompé farmaceutici S.p.A. | Il-8 inhibitors for use in the treatment of chemotherapy-induced peripheral neuropathy |
| RS62427B1 (sr) * | 2016-01-15 | 2021-11-30 | Dompe Farm Spa | Il-8 inhibitori za primenu u lečenju periferne neuropatije izazvane hemoterapijom |
| AU2017339942B2 (en) * | 2016-10-03 | 2023-06-29 | Dompe Farmaceutici S.P.A. | Prevention and treatment of diabetic nephropathy |
| GB201617871D0 (en) | 2016-10-21 | 2016-12-07 | Sareum Limited | Pharmaceutical compounds |
| US10660909B2 (en) | 2016-11-17 | 2020-05-26 | Syntrix Biosystems Inc. | Method for treating cancer using chemokine antagonists |
| EP3342407A1 (en) * | 2017-01-03 | 2018-07-04 | Dompé farmaceutici S.p.A. | Il-8 inihibitors for use in the treatment of some urological disorders |
| EP3409277A1 (en) * | 2017-05-30 | 2018-12-05 | Dompé farmaceutici s.p.a. | Il-8 inhibitors for use in the treatment and/or prevention of bacterial secondary infections |
| EP3476390A1 (en) * | 2017-10-24 | 2019-05-01 | Dompé farmaceutici S.p.A. | Il-8 inhibitors for use in the treatment of sarcomas |
| WO2019165315A1 (en) | 2018-02-23 | 2019-08-29 | Syntrix Biosystems Inc. | Method for treating cancer using chemokine antagonists alone or in combination |
| EP3868369A1 (en) | 2020-02-21 | 2021-08-25 | Dompe' Farmaceutici S.P.A. | Cxcl8 inhibitor and pharmaceutical composition thereof for use in the treatment of cancer-related fatigue |
| EP3868368A1 (en) | 2020-02-21 | 2021-08-25 | Dompe' Farmaceutici S.P.A. | Cxcl8 (interleukin-8) activity inhibitor and corticosteroid combination and pharmaceutical composition and use thereof |
| EP4008325A1 (en) | 2020-12-02 | 2022-06-08 | Dompe' Farmaceutici S.P.A. | Cxcl8 inhibitors for use in the treatment of covid-19 |
| CA3176715A1 (en) | 2020-03-26 | 2021-09-30 | Dompe' Farmaceutici Spa | Cxcl8 inhibitors for use in the treatment of covid-19 |
| EP3884932A1 (en) | 2020-03-26 | 2021-09-29 | Dompe' Farmaceutici S.P.A. | Cxcl8 inhibitors for use in the treatment of covid-19 |
| EP3907214A1 (en) * | 2020-05-04 | 2021-11-10 | Dompe' Farmaceutici S.P.A. | Co-crystal of ketoprofen, lysine and gabapentin, pharmaceutical compositions and their medical use |
| JP2023550598A (ja) | 2020-11-05 | 2023-12-04 | アイカーン スクール オブ メディシン アット マウント サイナイ | 骨髄線維症を治療する際に使用するためのｃｘｃｒ１／ｃｘｃｒ２阻害物質 |
| EP4052702A1 (en) | 2021-03-04 | 2022-09-07 | Dompé farmaceutici S.p.a. | Cxcl8 inhibitor and pharmaceutical composition thereof for use in the treatment of seizures |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1051906A (en) * | 1973-10-24 | 1979-04-03 | Shionogi And Co. | Thiazole derivatives and production thereof |
| US4025528A (en) * | 1973-10-24 | 1977-05-24 | Shionogi & Co., Ltd. | Thiazole derivatives of benzoic and phenylalkanoic acids |
| JPS565747B2 (it) * | 1973-10-24 | 1981-02-06 | ||
| JPS5537556B2 (it) * | 1973-12-27 | 1980-09-29 | ||
| JPS5629871B2 (it) * | 1974-05-22 | 1981-07-10 | ||
| JPS62142168A (ja) * | 1985-10-16 | 1987-06-25 | Mitsubishi Chem Ind Ltd | チアゾ−ル誘導体及びそれを有効成分とするロイコトリエンきつ抗剤 |
| IT1298214B1 (it) | 1998-01-28 | 1999-12-20 | Dompe Spa | Sali dell'acido (r) 2-(3-benzoilfenil) propionico e loro composizioni farmaceutiche. |
| IT1303249B1 (it) * | 1998-10-23 | 2000-11-06 | Dompe Spa | Alcune n-(2-aril-propionil)-solfonammidi e preparazionifarmaceutiche che le contengono. |
| IT1317826B1 (it) | 2000-02-11 | 2003-07-15 | Dompe Spa | Ammidi, utili nell'inibizione della chemiotassi dei neutrofiliindotta da il-8. |
| ITMI20012434A1 (it) | 2001-11-20 | 2003-05-20 | Dompe Spa | Acidi 2-aril-propionici e composizioni farmaceutiche che li contengono |
| EP1467981A1 (en) * | 2002-01-25 | 2004-10-20 | Kylix Pharmaceuticals B.V. | 4(hetero-) aryl substituted (thia-/oxa-/pyra) zoles for inhibition of tie-2 |
| AU2005223402B2 (en) * | 2004-03-23 | 2011-07-21 | Dompe' Farmaceutici S.P.A. | 2-phenylpropionic acid derivatives and pharmaceutical compositions containing them |
| CA2649794C (en) * | 2006-05-18 | 2016-02-16 | Dompe Pha.R.Ma S.P.A. | (2r)-2-[(4-sulfonyl)aminophenyl] propanamides and pharmaceutical compositions containing them |
| US8440711B2 (en) * | 2006-12-19 | 2013-05-14 | Dompe Pha.R.Ma S.P.A. | 2-aryl-2-fluoropropanoic acids and derivatives and pharmaceutical compositions containing them |
| CN101827841B (zh) * | 2007-10-18 | 2012-11-28 | 多派股份公司 | (r)-4-(杂芳基)苯乙基衍生物及其药物组合物 |
-
2008
- 2008-09-18 EP EP08164605A patent/EP2166006A1/en not_active Withdrawn
-
2009
- 2009-09-18 CN CN200980136860.5A patent/CN102159558B/zh active Active
- 2009-09-18 US US13/063,105 patent/US8624036B2/en active Active
- 2009-09-18 WO PCT/EP2009/062109 patent/WO2010031835A2/en active Application Filing
- 2009-09-18 ES ES09783167.1T patent/ES2534634T3/es active Active
- 2009-09-18 SI SI200931170T patent/SI2346841T1/sl unknown
- 2009-09-18 RU RU2011114992/04A patent/RU2520212C2/ru active
- 2009-09-18 AU AU2009294558A patent/AU2009294558B2/en active Active
- 2009-09-18 EP EP09783167.1A patent/EP2346841B1/en active Active
- 2009-09-18 DK DK09783167.1T patent/DK2346841T3/en active
- 2009-09-18 PL PL09783167T patent/PL2346841T3/pl unknown
- 2009-09-18 BR BRPI0918759A patent/BRPI0918759A2/pt not_active Application Discontinuation
- 2009-09-18 JP JP2011527334A patent/JP5571669B2/ja active Active
- 2009-09-18 PT PT97831671T patent/PT2346841E/pt unknown
- 2009-09-18 CA CA2737099A patent/CA2737099C/en active Active
-
2011
- 2011-03-10 IL IL211683A patent/IL211683A/en active IP Right Grant
-
2015
- 2015-04-08 CY CY20151100336T patent/CY1116176T1/el unknown
- 2015-04-09 HR HRP20150395TT patent/HRP20150395T1/hr unknown
- 2015-04-22 SM SM201500098T patent/SMT201500098B/it unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2346841A2 (en) | 2011-07-27 |
| JP5571669B2 (ja) | 2014-08-13 |
| AU2009294558A1 (en) | 2010-03-25 |
| PL2346841T3 (pl) | 2015-07-31 |
| ES2534634T3 (es) | 2015-04-27 |
| CN102159558A (zh) | 2011-08-17 |
| RU2011114992A (ru) | 2012-10-27 |
| WO2010031835A2 (en) | 2010-03-25 |
| IL211683A0 (en) | 2011-06-30 |
| PT2346841E (pt) | 2015-05-07 |
| EP2346841B1 (en) | 2015-01-14 |
| SI2346841T1 (sl) | 2015-07-31 |
| IL211683A (en) | 2014-01-30 |
| EP2166006A1 (en) | 2010-03-24 |
| US20110207785A1 (en) | 2011-08-25 |
| RU2520212C2 (ru) | 2014-06-20 |
| CY1116176T1 (el) | 2017-02-08 |
| US8624036B2 (en) | 2014-01-07 |
| BRPI0918759A2 (pt) | 2015-12-29 |
| CN102159558B (zh) | 2015-01-07 |
| HRP20150395T1 (hr) | 2015-06-19 |
| JP2012502957A (ja) | 2012-02-02 |
| WO2010031835A3 (en) | 2010-06-24 |
| CA2737099C (en) | 2016-07-05 |
| DK2346841T3 (en) | 2015-04-20 |
| CA2737099A1 (en) | 2010-03-25 |
| AU2009294558B2 (en) | 2014-12-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SMT201500098B (it) | Acidi 2-aril-propionici e derivati e composizioni farmaceutiche che li contengono | |
| IL254839B (en) | Derivatives of piperidine-4- and -2-carboxylic acids, perhydroazepine-4-carboxylic acid and (piperidin-4-yl)-acetic acid and pharmaceutical compositions comprising them | |
| DK2254908T3 (da) | Kosmetiske eller farmaceutiske sammensætninger omfattende metalloproteinasehæmmere | |
| SMAP201000003A (it) | Composizione, metodo e preparazione di acidi biliari sintetici | |
| SMT201600338B (it) | Formulazioni farmaceutiche comprendenti derivati di1-(beta-d- glucopiranosil)- 2-tienilmetilbenzene come inibitori di sglt | |
| DK2346495T4 (da) | Farmaceutisk formulering 514 | |
| BRPI0915300A2 (pt) | composto de éster boronato e composições farmaceuticas dos mesmos | |
| DK3360575T3 (da) | Transdermale farmaceutiske sammensætninger omfattende aktive stoffer | |
| EP2604260A4 (en) | NOVEL HETEROCYCLIC DERIVATIVES, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | |
| DK3246018T3 (da) | Farmaceutisk sammensætning | |
| SMT201400069B (it) | Formulazione farmaceutica | |
| SMT201400114B (it) | Derivati di 2-arilimidazolo come inibitori dell'enzima pde10a | |
| DK2391349T3 (da) | Farmaceutisk sammensætning omfattende 2-oco-1-pyrrolidin-derivater | |
| DK2654736T3 (da) | Hidtil ukendt farmaceutisk sammensætning | |
| BRPI0921654A2 (pt) | formulação farmacêutica | |
| DK2164520T3 (da) | Cyclodextriner til indgivelse af fedtsyrer i tabletter | |
| BR112012023355A2 (pt) | composto, composição farmacêutica e método de ruptura da interação nek2/hec1 | |
| CR10665A (es) | Nuevos derivados de diosmetina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
| DK2391351T3 (da) | Farmaceutisk sammensætning omfattende 2-oxo-1-pyrrolidinderivater | |
| EP2277861A4 (en) | CYCLIC AMIN-1-CARBOXYLIC ACID EST DERIVATIVE AND PHARMACEUTICAL COMPOSITION THEREWITH | |
| BRPI0917492A8 (pt) | processos para preparação de metil éster de ácido 4-oxo-octa-hidro-indol-1-carboxílico e derivados dos mesmos | |
| BRPI0917562A2 (pt) | composições farmacêuticas e métodos para estabilizar as mesmas | |
| BRPI0912171A2 (pt) | composição farmacêutica | |
| BR112013010074A2 (pt) | composição celulósica e produto | |
| UY33128A (es) | Derivados de piridinona y composiciones farmacéuticas de los mismos |